Matches in Nanopublications for { ?s ?p "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_provenance.
- NP600110.RAGIDVGW_mXtni3K44tcBJt2PDyPOcE-NUYX1lFTbHtxw130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600110.RAGIDVGW_mXtni3K44tcBJt2PDyPOcE-NUYX1lFTbHtxw130_provenance.
- assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_provenance.
- NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798754.RAsN7Q7NLV9--l7Vo1Q9f-fGD9_XPAOJTTFouJk1evTj4130_provenance.
- NP798753.RAOI2HiPOWssWasASYMkU7TSa9NwcdTc7XlmtkQL14egQ130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798753.RAOI2HiPOWssWasASYMkU7TSa9NwcdTc7XlmtkQL14egQ130_provenance.
- NP690114.RAHI5U4G8ziRYDyqSzw3Qp79SSNRmsAJLbHxrVXTaleHA130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690114.RAHI5U4G8ziRYDyqSzw3Qp79SSNRmsAJLbHxrVXTaleHA130_provenance.